Asymptomatic carotid artery stenosis and the risk of ischemic stroke according to subtype in patients with clinical manifest arterial disease

Stroke

Volumn 44, Issue 4, 2013, Pages 1002-1007

  Den Hartog, Anne G ^a   Achterberg, Sefanja ^a   Moll, Frans L ^a   Kappelle, L Jaap ^a   Visseren, Frank L J ^a   Van Der Graaf, Yolanda ^a   Algra, Ale ^a   De Borst, Gert Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Asymptomatic carotid artery stenosis; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; ASYMPTOMATIC CAROTID ARTERY STENOSIS; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; BRAIN ISCHEMIA; CAROTID ARTERIES; CAROTID STENOSIS; COHORT STUDIES; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECURRENCE; RISK; RISK FACTORS; STROKE; ULTRASONOGRAPHY; VASCULAR DISEASES;

EID: 84876287011     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.669267     Document Type: Article

References (30)

1. Abbott AL, Chambers BR, Stork JL, Levi CR, Bladin CF, Donnan GA. Embolic signals and prediction of ipsilateral stroke or transient ischemic attack in asymptomatic carotid stenosis. Stroke. 2005;36:1128-1133.
2. de Weerd M, Greving JP, Hedblad B, Lorenz MW, Mathiesen EB, O'Leary DH, et al. Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-Analysis. Stroke. 2010;41:1294-1297.
3. Inzitari D, Eliasziw M, Gates P, Sharpe BL, Chan RK, Meldrum HE et al. The causes and risk of stroke in patients with asymptomatic internalcarotid- Artery stenosis. N Engl J Med. 2000;342:1693-1700.
4. Nadareishvili ZG, Rothwell PM, Beletsky V, Pagniello A, Norris JW. Long-Term risk of stroke and other vascular events in patients with asymptomatic carotid artery stenosis. Arch Neurol. 2002;59:1162-1166.
5. Norris JW, Zhu CZ, Bornstein NM, Chambers BR. Vascular risks of asymptomatic carotid stenosis. Stroke. 1991;22:1485-1490.
6. Goessens BM, Visseren FL, Kappelle LJ, Algra A, van der Graaf Y. Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease: the SMART study. Stroke. 2007;38:1470-1475.
7. Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke. 2009;40:e573-e583.
8. Naylor AR, Gaines PA, Rothwell PM. Who benefits most from intervention for asymptomatic carotid stenosis: patients or professionals? Eur J Vasc Endovasc Surg. 2009;37:625-632.
9. Spence JD. Asymptomatic carotid stenosis: mainly a medical condition. Vascular. 2010;18:123-6; discussion 127.
10. Goldstein LB, Jones MR, Matchar DB, Edwards LJ, Hoff J, Chilukuri V, et al. Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke. 2001;32:1091-1098.
11. Simons PC, Algra A, van de Laak MF, Grobbee DE, van der Graaf Y. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol. 1999;15:773-781.
12. Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis. Radiology. 2003;229:340-346.
13. Pruissen DM, Gerritsen SA, Prinsen TJ, Dijk JM, Kappelle LJ, Algra A; SMART Study Group. Carotid intima-media thickness is different in large-And small-vessel ischemic stroke: the SMART study. Stroke. 2007;38:1371-1373.
14. Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J, et al.; Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet. 2010;376:1074-1084.
15. Achterberg S, Cramer MJ, Kappelle LJ, de Borst GJ, Visseren FL, van der Graaf Y, et al.; SMART study Group. Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study. Eur J Cardiovasc Prev Rehabil. 2010;17:424-430.
16. Marquardt L, Geraghty OC, Mehta Z, Rothwell PM. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke. 2010;41:e11-e17.
17. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al.; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-2207.
18. Vlek A, Visseren F, Algra A, Soedamah-Muthu S, Moll F, Doevendans P, et al.; SMART study group. Trends in vascular risk factors and medication use in patients with various manifestations of vascular diseases or type 2 diabetes mellitus from 1996 to 2007: the Second Manifestations of ARTerial disease study. Eur J Cardiovasc Prev Rehabil. 2010;17:628-636.
19. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
20. Gordon DL, Bendixen BH, Adams HP Jr, Clarke W, Kappelle LJ, Woolson RF. Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. Neurology. 1993;43:1021-1027.
21. Jackson CA, Hutchison A, Dennis MS, Wardlaw JM, Lindgren A, Norrving B, et al. Differing risk factor profiles of ischemic stroke subtypes: evidence for a distinct lacunar arteriopathy? Stroke. 2010;41:624-629.
22. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, de Simone G. et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121:e46-e215.
23. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation. 2005;111:1327-1331.
24. Ballotta E, Da Giau G, Meneghetti G, Barbon B, Militello C, Baracchini C. Progression of atherosclerosis in asymptomatic carotid arteries after contralateral endarterectomy: a 10-year prospective study. J Vasc Surg. 2007;45:516-522.
25. Rockman CB, Riles TS, Lamparello PJ, Giangola G, Adelman MA, Stone D, et al. Natural history and management of the asymptomatic, moderately stenotic internal carotid artery. J Vasc Surg. 1997;25:423-431.
26. Hellings WE, Peeters W, Moll FL, Piers SR, van Setten J, Van der Spek PJ, et al. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation. 2010;121:1941-1950.
27. Rundek T, Arif H, Boden-Albala B, Elkind MS, Paik MC, Sacco RL. Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology. 2008;70:1200-1207.
28. Nicolaides AN, Kakkos SK, Kyriacou E, Griffin M, Sabetai M, Thomas DJ, et al.; Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification. J Vasc Surg. 2010;52:1486-1496.e1.
29. Rockman C, Riles T. Carotid artery disease: selecting the appropriate asymptomatic patient for intervention. Perspect Vasc Surg Endovasc Ther. 2010;22:30-37.
30. Held C, Hjemdahl P, Eriksson SV, Björkander I, Forslund L, Rehnqvist N. Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. Eur Heart J. 2001;22:62-72.